The results showed DL-arginine treatment resulted in significantly upregulated GLUT type 4 (GLUT4) expression in the skeletal muscle compared with STZ-induced T2DM rats (p < 0.01), while GLUT2 expression had no significant change in the liver (p > 0.05). Here, SLC2A2 is linked to type 2 diabetes mellitus.